Gallagher Cam 4

What Happened

• Cam Gallagher, a director of Opus Genetics, was granted 24,367 restricted stock units (RSUs) on April 20, 2026. The reported acquisition price is $0.00, so the grant had no immediate cash cost to Gallagher.

Key Details

• Transaction date: 2026-04-20; Filing date: 2026-04-22 (filed within typical Section 16 timing).
• Transaction type/code: A (award/grant).
• Shares/units granted: 24,367 RSUs; reported acquisition price: $0.00; immediate dollar value at grant: $0.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote F1: RSUs vest on the earlier of one year from the grant or the day before the issuer’s next annual meeting, subject to Gallagher’s continued service through the vesting date.
• Footnote F2: Some securities are held of record by Gallagher as custodian for a minor under a Uniform Transfer to Minors Act account; he disclaims beneficial ownership except to the extent of any pecuniary interest.

Context

• RSUs are a form of compensation: they convert into actual shares only upon vesting and are not an open-market purchase or sale. Grants like this are commonly used for director compensation and retention and do not by themselves indicate a buying or selling signal.